BACKGROUND AND PURPOSE: The modulation by flavonoids of platelet responses induced by thrombin has been little investigated, and the antiplatelet activity, as well as possible inhibitory mechanisms of these compounds on thrombin signalling, has not yet been elucidated. We explored whether flavonoids affect platelet signalling pathways triggered by thrombin and by the selective activation of its protease-activated receptors (PARs) 1 and 4, and analysed the antagonism of these polyphenols at thrombin receptors. EXPERIMENTAL APPROACH: We investigated the effect of a range of polyphenolic compounds on platelet aggregation, 5-HT secretion, intracellular calcium mobilization, protein kinase activity and tyrosine phosphorylation, triggered by thrombin and PAR agonist peptides (PAR-APs). The ability of these flavonoids to bind to thrombin receptors was investigated by competitive radioligand binding assays using (125)I-thrombin. KEY RESULTS: Quercetin, apigenin and genistein impaired platelet aggregation, as well as 5-HT release and calcium mobilization, induced by thrombin and PAR-APs. Quercetin and apigenin were inhibitors of protein kinases, but genistein exhibited a minimal ability to suppress platelet phosphorylation. Binding assays did not establish any kind of interaction between thrombin receptors and any of the flavonoids tested. CONCLUSIONS AND IMPLICATIONS: Quercetin, apigenin and genistein did not inhibit thrombin responses by interacting with thrombin receptors, but by interfering with intracellular signalling. While inhibition by genistein may be a consequence of affecting calcium mobilization, subsequent platelet secretion and aggregation, for quercetin and apigenin, inhibition of kinase activation may also be involved in the impairment of platelet responses.
BACKGROUND AND PURPOSE: The modulation by flavonoids of platelet responses induced by thrombin has been little investigated, and the antiplatelet activity, as well as possible inhibitory mechanisms of these compounds on thrombin signalling, has not yet been elucidated. We explored whether flavonoids affect platelet signalling pathways triggered by thrombin and by the selective activation of its protease-activated receptors (PARs) 1 and 4, and analysed the antagonism of these polyphenols at thrombin receptors. EXPERIMENTAL APPROACH: We investigated the effect of a range of polyphenolic compounds on platelet aggregation, 5-HT secretion, intracellular calcium mobilization, protein kinase activity and tyrosine phosphorylation, triggered by thrombin and PAR agonist peptides (PAR-APs). The ability of these flavonoids to bind to thrombin receptors was investigated by competitive radioligand binding assays using (125)I-thrombin. KEY RESULTS:Quercetin, apigenin and genisteinimpaired platelet aggregation, as well as 5-HT release and calcium mobilization, induced by thrombin and PAR-APs. Quercetin and apigenin were inhibitors of protein kinases, but genistein exhibited a minimal ability to suppress platelet phosphorylation. Binding assays did not establish any kind of interaction between thrombin receptors and any of the flavonoids tested. CONCLUSIONS AND IMPLICATIONS: Quercetin, apigenin and genistein did not inhibit thrombin responses by interacting with thrombin receptors, but by interfering with intracellular signalling. While inhibition by genistein may be a consequence of affecting calcium mobilization, subsequent platelet secretion and aggregation, for quercetin and apigenin, inhibition of kinase activation may also be involved in the impairment of platelet responses.
Authors: Martin Steinhoff; Jörg Buddenkotte; Victoria Shpacovitch; Anke Rattenholl; Corinna Moormann; Nathalie Vergnolle; Thomas A Luger; Morley D Hollenberg Journal: Endocr Rev Date: 2005-02 Impact factor: 19.871
Authors: M L Kahn; Y W Zheng; W Huang; V Bigornia; D Zeng; S Moff; R V Farese; C Tam; S R Coughlin Journal: Nature Date: 1998-08-13 Impact factor: 49.962
Authors: Javad Sharifi-Rad; Cristina Quispe; Wissam Zam; Manoj Kumar; Susana M Cardoso; Olivia R Pereira; Adedayo O Ademiluyi; Oluwakemi Adeleke; Ana Catarina Moreira; Jelena Živković; Felipe Noriega; Seyed Abdulmajid Ayatollahi; Farzad Kobarfard; Mehrdad Faizi; Miquel Martorell; Natália Cruz-Martins; Monica Butnariu; Iulia Cristina Bagiu; Radu Vasile Bagiu; Mohammed M Alshehri; William C Cho Journal: Oxid Med Cell Longev Date: 2021-08-17 Impact factor: 6.543
Authors: Yan Yang; Zhenyin Shi; Adili Reheman; Joseph W Jin; Conglei Li; Yiming Wang; Marc C Andrews; Pingguo Chen; Guangheng Zhu; Wenhua Ling; Heyu Ni Journal: PLoS One Date: 2012-05-18 Impact factor: 3.240
Authors: Ji Young Park; Hyun Dong Ji; Bo Ra Jeon; Eun Ju Im; Young Min Son; Joo Young Lee; Dong-Ha Lee; Young-Chul Lee; Eujin Hyun; Qi Jia; Mei Hong; Hwa-Jin Park; Man Hee Rhee Journal: Evid Based Complement Alternat Med Date: 2013-08-13 Impact factor: 2.629
Authors: Thomas M Vallance; Divyashree Ravishankar; Dina A I Albadawi; Helen M I Osborn; Sakthivel Vaiyapuri Journal: Int J Mol Sci Date: 2019-06-25 Impact factor: 5.923
Authors: Renato Simões Gaspar; Samira Abdalla da Silva; Jennifer Stapleton; João Lucas de Lima Fontelles; Hiran Reis Sousa; Vinicyus Teles Chagas; Shuruq Alsufyani; Andrés Trostchansky; Jonathan M Gibbins; Antonio Marcus de Andrade Paes Journal: Front Pharmacol Date: 2020-01-31 Impact factor: 5.810